AT
The startup offers an oncology-specific teleconsultation platform that connects cancer patients in Hong Kong with global oncology experts for remote consultations and eligibility assessments for clinical trials. This platform addresses the challenge of limited access to specialized cancer care by providing timely online consultations and streamlined pathways to clinical trial participation.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup offers an oncology-specific teleconsultation platform that connects cancer patients in Hong Kong with global oncology experts for remote consultations and eligibility assessments for clinical trials. This platform addresses the challenge of limited access to specialized cancer care by providing timely online consultations and streamlined pathways to clinical trial participation.